Stanford Cancer Institute Breakthroughs in Cancer

Stanford Cancer Institute’s recurring seminar series Breakthroughs in Cancer, is one of the highest-profile seminar series for translational and clinical scientists in oncology.  

The series highlights innovations in cancer research across the spectrum of basic, translational, clinical, and population science. Speakers include national thought leaders and dynamic presenters representing a broad range of disciplines across the spectrum of cancer science. The audience for this seminar series includes Stanford University and Stanford Medicine faculty, trainees, staff, and anyone interested in basic, translational, clinical, and population-based cancer research.

Seminars are held on the second Tuesday of the month in-person and via Zoom from 4:00 p.m. - 5:00 p.m. at Munzer Auditorium in the Beckman Building, followed by an in-person reception.

Upcoming Seminars

Mar 12 | 4pm PT

Paul Buckley, PhD

Vice President, Chief Diversity, Equity & Inclusion Office
Fred Hutchinson Cancer Research Center

Title: The Cost of DEI

Jun 11 | 4pm PT

Barbara Bierer, MD
Professor of Medicine (Pediatrics)
Harvard Medical School

Jul 9 | 4pm PT

Ron Levy, MD
Associate Director, Translational Science
Stanford Cancer Institute

Sep 10 | 4pm PT

Iannis Aifantis, PhD
Chair, Department of Pathology
New York University

Title: 3D chromosomal architecture in acute leukemia: impact on disease progression and drug response

Nov 12 | 4pm PT

Cornelia Ulrich, PhD, MS
Chief Scientific Officer and Executive Director
Huntsman Cancer Institute


Past 2024 Seminars

The Best Cancer Is The Cancer That Never Happens

Philip Castle, PhD, MPH
Director of the Division of Cancer Prevention
National Cancer Institute



For questions contact:
Athena Serapio